STOCK TITAN

Curaleaf Reports on Voting Results from the 2024 Annual General Meeting of Shareholders

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
Rhea-AI Summary

Curaleaf Holdings held its 2024 Annual General Meeting of Shareholders on June 14, 2024, via live webcast. A total of 1,741,506,378 votes were cast. Key decisions included the re-election of directors with high approval rates: Boris Jordan (98.515%), Joseph Lusardi (98.931%), Dr. Jaswinder Grover (99.906%), Karl Johansson (99.587%), Peter Derby (99.253%), Mitchell Kahn (98.736%), Shasheen Shah (99.848%), and Michelle Bodner (98.873%). Shareholders also approved the reappointment of PKF O'Connor Davies, LLP as the auditor and set the number of directors to 10. Detailed voting results are available on SEDAR+ and EDGAR.

Positive
  • High shareholder participation with 1,741,506,378 votes cast.
  • Directors re-elected with overwhelming approval rates exceeding 98%.
  • Approval of PKF O'Connor Davies, LLP as auditor reaffirms financial stability.
  • Decision to maintain 10 directors ensures continuity.
Negative
  • No new strategic initiatives or business developments were announced.
  • Lack of information on financial performance or future outlook.

NEW YORK, June 14, 2024 /PRNewswire/ -- The Annual General Meeting of Shareholders  of Curaleaf Holdings, Inc. (TSX: CURA) (OTCQX: CURLF) ("Curaleaf" or the "Company"), a leading international provider of consumer cannabis products, was held today via live webcast online. Each of the matters voted upon at the meeting is discussed in detail in the Company's management information circular dated May 6, 2024 (the "Circular"), which can be found under the Company's profile on SEDAR+ (www.sedarplus.ca) and on EDGAR (https://www.sec.gov/edgar).

The total number of votes cast by shareholders in person or represented by proxy at the meeting was 1,741,506,378 votes (with each subordinate voting share entitling the holder thereof to one vote, and each multiple voting share entitling the holder thereof to 15 votes). The voting results in relation to the election of directors were as follows:


Percentage of Votes

Name of Director

For

Withheld

Boris Jordan

98.515

1.485

Joseph Lusardi

98.931

1.069

Dr. Jaswinder Grover

99.906

0.094

Karl Johansson

99.587

0.413

Peter Derby

99.253

0.747

Mitchell Kahn

98.736

1.264

Shasheen Shah

99.848

0.152

Michelle Bodner

98.873

1.127

In addition, the number of directors of the Company was also set by the shareholders of Curaleaf at 10 directors, and the resolution with respect to the reappointment of PKF O'Connor Davies, LLP as the Company's auditor put before shareholders for consideration and approval at the meeting, as described in the Circular, was duly approved by the requisite number of votes. The Company has filed a report of voting results on all resolutions voted on at the meeting under its profile on www.sedarplus.ca and on www.sec.gov/edgar.

About Curaleaf Holdings

Curaleaf Holdings, Inc. (TSX: CURA) (OTCQX: CURLF) ("Curaleaf") is a leading international provider of consumer products in cannabis with a mission to enhance lives by cultivating, sharing and celebrating the power of the plant. As a high-growth cannabis company known for quality, expertise and reliability, the Company and its brands, including Curaleaf, Select, Grassroots, JAMS, Find and Zero Proof provide industry-leading service, product selection and accessibility across the medical and adult use markets. Curaleaf International is the largest vertically integrated cannabis company in Europe with a unique supply and distribution network throughout the European market, bringing together pioneering science and research with cutting-edge cultivation, extraction and production. Curaleaf is listed on the Toronto Stock Exchange under the symbol CURA and trades on the OTCQX market under the symbol CURLF. For more information, please visit https://ir.curaleaf.com.

Forward Looking Statements

This media advisory contains forward-looking statements and forward-looking information within the meaning of applicable securities laws. These statements relate to future events or future performance. All statements other than statements of historical fact may be forward–looking statements or information. Generally, forward-looking statements and information may be identified by the use of forward-looking terminology such as "plans", "expects" or, "proposed", "is expected", "intends", "anticipates", or "believes", or variations of such words and phrases, or by the use of words or phrases which state that certain actions, events or results may, could, would, or might occur or be achieved. Such forward-looking statements and information reflect management's current beliefs and are based on assumptions made by and information currently available to the company with respect to the matter described in this new release. Forward-looking statements involve risks and uncertainties, which are based on current expectations as of the date of this release and subject to known and unknown risks and uncertainties that could cause actual results to differ materially from those expressed or implied by such statements. Additional information about these assumptions and risks and uncertainties is contained under "Risk Factors and Uncertainties" in the Company's latest annual information form filed on March 6, 2024, which is available under the Company's SEDAR+ profile at www.sedarplus.ca, and in other filings that the Company has made and may make with applicable securities authorities in the future. Forward-looking statements contained herein are made only as to the date of this press release and we undertake no obligation to update or revise any forward-looking statements whether as a result of new information, future events or otherwise, except as required by law. We caution investors not to place considerable reliance on the forward-looking statements contained in this press release. The Toronto Stock Exchange has not reviewed, approved or disapproved the content of this news release.

INVESTOR CONTACT
Curaleaf Holdings, Inc.
Camilo Lyon, Chief Investment Officer
IR@curaleaf.com

MEDIA CONTACT
Curaleaf Holdings, Inc.
Tracy Brady, SVP Corporate Communications
media@curaleaf.com

Cision View original content:https://www.prnewswire.com/news-releases/curaleaf-reports-on-voting-results-from-the-2024-annual-general-meeting-of-shareholders-302173401.html

SOURCE Curaleaf Holdings, Inc.

FAQ

What were the results of the 2024 Curaleaf Annual General Meeting?

The meeting resulted in the re-election of directors with approval rates above 98%, the reappointment of PKF O'Connor Davies, LLP as auditor, and the decision to maintain 10 directors.

How many votes were cast in the 2024 Curaleaf shareholder meeting?

A total of 1,741,506,378 votes were cast at the 2024 Curaleaf shareholder meeting.

Who received the highest approval rate for re-election to the Curaleaf Board of Directors in 2024?

Dr. Jaswinder Grover received the highest approval rate with 99.906%.

Was the auditor reappointed at the 2024 Curaleaf Annual General Meeting?

Yes, PKF O'Connor Davies, LLP was reappointed as the auditor.

How many directors will Curaleaf have following the 2024 Annual General Meeting?

Curaleaf will maintain 10 directors following the 2024 Annual General Meeting.

CURALEAF HLDGS INC

OTC:CURLF

CURLF Rankings

CURLF Latest News

CURLF Stock Data

1.26B
595.63M
29.87%
2.97%
Drug Manufacturers - Specialty & Generic
Healthcare
Link
United States of America
New York